Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723783 | SCV000202839 | uncertain significance | not provided | 2015-07-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089384 | SCV000288916 | likely benign | Brugada syndrome 8 | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000247393 | SCV000319923 | likely benign | Cardiovascular phenotype | 2015-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000723783 | SCV000722602 | likely benign | not provided | 2019-10-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000723783 | SCV001144131 | likely benign | not provided | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000723783 | SCV001149539 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | HCN4: BP4, BP7 |
Diagnostic Laboratory, |
RCV000723783 | SCV001744551 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000153355 | SCV001918230 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000723783 | SCV001928146 | likely benign | not provided | no assertion criteria provided | clinical testing |